Hairy cell leukemia: a successful model for experimental therapeutics—pentostatin and new ideas

Combination therapies to improve the long-term outcome in hairy cell leukemia

(2010) Francesco Lauria et al.   LEUKEMIA & LYMPHOMA

Long-term follow-up studies in hairy cell leukemia

(2010) Michael R. Grever et al.   LEUKEMIA & LYMPHOMA

Approach to the patient after relapse of hairy cell leukemia

(2010) Robert J. Kreitman et al.   LEUKEMIA & LYMPHOMA

Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy

(2010) Deborah A. Thomas et al.   LEUKEMIA & LYMPHOMA

How I treat hairy cell leukemia

(2009) M. R. Grever   BLOOD

The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo

(2009) David M. Lucas et al.   BLOOD

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

(2009) Monica Else et al.   BRITISH JOURNAL OF HAEMATOLOGY

Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia

(2009) Robert J. Kreitman et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized trial of dailyversusweekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)

(2009) R. Zenhäusern et al.   LEUKEMIA & LYMPHOMA

Hairy Cell Leukemia: Treatment Successes in the Past 25 Years

(2008) Harvey M. Golomb   JOURNAL OF CLINICAL ONCOLOGY